Clinical Trial Update: NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating nimorazole plus radiotherapy versus radiotherapy alone in locally advanced head and neck squamous cell carcinoma not suitabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimorazole (nimorazole)
• Radiotherapy

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED